Changping Laboratory, Beijing, China.
Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
Nat Cancer. 2024 Sep;5(9):1409-1426. doi: 10.1038/s43018-024-00807-z. Epub 2024 Aug 15.
The tumor microenvironment (TME) considerably influences colorectal cancer (CRC) progression, therapeutic response and clinical outcome, but studies of interindividual heterogeneities of the TME in CRC are lacking. Here, by integrating human colorectal single-cell transcriptomic data from approximately 200 donors, we comprehensively characterized transcriptional remodeling in the TME compared to noncancer tissues and identified a rare tumor-specific subset of endothelial cells with T cell recruitment potential. The large sample size enabled us to stratify patients based on their TME heterogeneity, revealing divergent TME subtypes in which cancer cells exploit different immune evasion mechanisms. Additionally, by associating single-cell transcriptional profiling with risk genes identified by genome-wide association studies, we determined that stromal cells are major effector cell types in CRC genetic susceptibility. In summary, our results provide valuable insights into CRC pathogenesis and might help with the development of personalized immune therapies.
肿瘤微环境(TME)极大地影响了结直肠癌(CRC)的进展、治疗反应和临床结局,但目前缺乏关于 CRC 中 TME 个体间异质性的研究。在这里,我们通过整合来自大约 200 位供体的人类结直肠单细胞转录组数据,全面描述了 TME 与非癌组织相比的转录重编程,并鉴定出具有招募 T 细胞潜力的罕见肿瘤特异性内皮细胞亚群。大样本量使我们能够根据 TME 异质性对患者进行分层,揭示了不同的 TME 亚型,其中癌细胞利用不同的免疫逃避机制。此外,通过将单细胞转录谱与全基因组关联研究确定的风险基因相关联,我们确定基质细胞是 CRC 遗传易感性的主要效应细胞类型。总之,我们的研究结果为 CRC 的发病机制提供了有价值的见解,并可能有助于开发个性化免疫疗法。
Clin Transl Med. 2021-6
Nat Rev Genet. 2025-8-20
World J Gastrointest Oncol. 2025-7-15
World J Gastroenterol. 2025-7-7
Nat Commun. 2023-1-14